Several patterns emerge from this data
Phase 3 TRIUMPH titration (current standard) Phase 3 TRIUMPH retatrutide titration schedule Phase Initiation Weeks Weeks 1-4 Weekly Dose 1 mg Notes Starting dose
Fredrick, F., Aggarwal, K., Reddy Meda, A
Animal Research Animal research contributes to Retatrutides broader evidence landscape by allowing controlled exploration of pathway-level questions that cannot be fully isolated in human trials
In the SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., NEJM 2015), participants receiving Saxenda alongside lifestyle modification achieved mean weight loss of approximately 8% of initial body weight, compared with 2.6% in the placebo group
This trend underscores the resilience of the compounding segment and raises important questions about enforcement, clinical oversight, and the future role of compounded therapies in chronic disease management